Resources

Stay informed with the latest publications, data, and webinars showcasing innovation and progress in the cell and gene therapy sector.

Q1 2026 Cell & Gene Therapy Sector Snapshot

Featured Resource

Q1 2026 Cell & Gene Therapy Sector Snapshot

A recap of the notable cell and gene therapy clinical, regulatory, and investment trends from Q1 2026.

Invisible but Critical: Managing Process Residuals in Cell Therapies

Featured Resource

Invisible but Critical: Managing Process Residuals in Cell Therapies

Resource Filters

Results

Comments & Letters, Press Releases

ARM Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and the Accelerating Kids Access to Care Act

Comments & Letters, Press Releases

ARM Statement on the Publication of the EU Biotech Act

Comments & Letters, Press Releases

ARM Applauds House Passage of the Mikaela Naylon Give Kids a Chance Act

ARM Announces Election of 2026 Board of Directors

ARM Applauds FDA’s Elimination of REMS Requirements and Labeling Changes for Autologous CAR-T Cell Therapies

ARM's Statement on the Departure of OTP Director Nicole Verdun and Deputy Director Rachael Anatol

ARM and JSRM Announce Agreement to Foster Scientific Collaboration for Regenerative Medicine Between the U.S. and Japan

Leading Gene and Cell Therapy Organizations Call for a 10-year Moratorium on Heritable Human Genome Editing

ARM Issues Statement on Dr. Peter Marks and the FDA’s Office of Therapeutic Products

The Alliance for Regenerative Medicine Announces Election of 2025 Board of Directors

Stay Informed Subscribe Today

Sign up for ARM’s weekly newsletter on sector news and alerts for events, reports, and other engagement opportunities.

Subscribe